TSE:WEED Canopy Growth (WEED) Stock Price, News & Analysis C$4.04 +0.14 (+3.59%) (As of 12/20/2024 05:18 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades About Canopy Growth Stock (TSE:WEED) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Canopy Growth alerts:Sign Up Key Stats Today's RangeC$3.89▼C$4.1450-Day RangeC$3.90▼C$7.7752-Week RangeC$3.74▼C$20.50Volume2.00 million shsAverage Volume2.06 million shsMarket CapitalizationC$342.83 millionP/E RatioN/ADividend Yield4.80%Price TargetC$6.26Consensus RatingStrong Sell Company OverviewCanopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players; and partnership with Parent Action on Drugs. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.Read More… Canopy Growth Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks25th Percentile Overall ScoreWEED MarketRank™: Canopy Growth scored higher than 25% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.6 / 5Analyst RatingStrong Sell Consensus RatingCanopy Growth has received a consensus rating of Strong Sell. The company's average rating score is 1.25, and is based on no buy ratings, 1 hold rating, and 3 sell ratings.Amount of Analyst CoverageCanopy Growth has only been the subject of 1 research reports in the past 90 days.Read more about Canopy Growth's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Canopy Growth is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Canopy Growth is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioDue to a projected decrease in earnings for Canopy Growth, their PEG ratio cannot be calculated.Price to Book Value per Share RatioCanopy Growth has a P/B Ratio of 0.61. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for WEED. Dividend1.7 / 5Dividend StrengthWeak Dividend LeadershipCanopy Growth is a leading dividend payer. It pays a dividend yield of 4.80%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthCanopy Growth does not have a long track record of dividend growth.Read more about Canopy Growth's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for WEED. News and Social Media1.9 / 5News Sentiment0.38 News SentimentCanopy Growth has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Canopy Growth this week, compared to 3 articles on an average week.Search InterestOnly 2 people have searched for WEED on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Canopy Growth insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.21% of the stock of Canopy Growth is held by insiders.Percentage Held by InstitutionsOnly 9.36% of the stock of Canopy Growth is held by institutions.Read more about Canopy Growth's insider trading history. Receive WEED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Canopy Growth and its competitors with MarketBeat's FREE daily newsletter. Email Address WEED Stock News HeadlinesCanopy Growth Corp WEEDDecember 21 at 8:15 PM | morningstar.comCanopy Growth (TSE:WEED) Stock Rating Lowered by ATB CapitalDecember 18, 2024 | americanbankingnews.comWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.December 22, 2024 | Behind the Markets (Ad)Canopy Growth Stock Rises As Acreage Acquisition Comes To A Close: Retail Eyes More UpsideDecember 9, 2024 | msn.comCanopy Growth Unveils Festive Cannabis DelightsDecember 5, 2024 | markets.businessinsider.comCanopy Growth Nears Completion of Acreage AcquisitionDecember 2, 2024 | tipranks.comStockTalk | Cannabis Report: New CEO, new dispensaries, new strainsNovember 29, 2024 | msn.comCanopy Growth names Luc Mongeau as the cannabis company's next CEONovember 27, 2024 | msn.comSee More Headlines WEED Stock Analysis - Frequently Asked Questions How have WEED shares performed this year? Canopy Growth's stock was trading at C$6.76 at the start of the year. Since then, WEED stock has decreased by 40.2% and is now trading at C$4.04. View the best growth stocks for 2024 here. How do I buy shares of Canopy Growth? Shares of WEED stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Canopy Growth own? Based on aggregate information from My MarketBeat watchlists, some other companies that Canopy Growth investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Aurora Cannabis (ACB), Aphria (APHA), Meta Platforms (META), NVIDIA (NVDA) and Auxly Cannabis Group (CBWTF). Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryCannabis Current SymbolTSE:WEED CUSIPN/A CIKN/A Webwww.canopygrowth.com Phone+1-613-5999600FaxN/AEmployees2,700Year FoundedN/APrice Target and Rating Average Stock Price TargetC$6.26 High Stock Price TargetC$11.00 Low Stock Price TargetC$3.50 Potential Upside/Downside+55.0%Consensus RatingStrong Sell Rating Score (0-4)1.25 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)C($7.91) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth-0.01Net IncomeC$-602,300,000.00 Net Margins-259.94% Pretax MarginN/A Return on Equity-87.26% Return on Assets-3.83% Debt Debt-to-Equity Ratio117.00 Current Ratio2.15 Quick Ratio2.32 Sales & Book Value Annual SalesC$287.10 million Price / Sales1.19 Cash FlowC$2.48 per share Price / Cash Flow1.63 Book ValueC$6.58 per share Price / Book0.61Miscellaneous Outstanding Shares84,860,000Free FloatN/AMarket CapC$342.83 million OptionableNot Optionable Beta1.79 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report This page (TSE:WEED) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Canopy Growth Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Canopy Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.